Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program
Clinical trial NCT04632953 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04632953
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-30
- Primary completion
- 2035-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.